Skip to main content

Carboplatin Uses, Side Effects, and More

 Carboplatin

Brand name:-  Oncocarbin 150mg inj. ,  Kemocarb150,450 mg/Vail inj. 400mg/m² .

 Carboplatin is an anti-cancer medication . It is a less reactive second generation platinum compound that is better tolerated and has a toxicity profile different from Cisplatin.It works by damaging the genetic material (DNA and RNA) of the cancer cells which stops their growth and multiplication.

Pharmacodynamic:- 


Carboplatin is an organoplatinum antineoplastic alkylating agent used in the treatment of advanced ovarian carcinoma. Carboplatin has a long duration of action as it is given every  weeks, and a narrow therapeutic index. Patients should be counselled regarding bone marrow suppression and anemia.

Pharmacokinetics:-

After a 1 hour infusion of carboplatin, the blood levels of total platinum and free platinum reduce in a biphasic manner. For the free platinum, the first phase of the half life (when the drug achieves half its plasma concentration) is around 90 minutes. In the later phase, the half life is around 6 hours. All free platinum is in the form of carboplatin for the first four hours.

Once administered, the drug binds to plasma proteins. Protein binding is less than with cisplatin. Initially, protein binding is low, with around 29% of the carboplatin bound in the first 4 hours. However, within 24 hours, 85-89% of the platinum in the drug is bound irreversibly to the plasma proteins and is gradually eliminated with a minimum half life of five days.

Carboplatin is excreted via the kidneys. Most of the excretion occurs within the first 6 hours after the drug is administered and around 50% to 60% is excreted within 24 hours. Of all the medication administered, 32% is excreted unchanged in urine.

Mechanism of action:- 

Carboplatin undergoes activation inside cells and forms reactive platinum complexes that cause the intra- and inter-strand cross-linkage of DNA molecules within the cell. This modifies the DNA structure and inhibits DNA synthesis. This may affect a cell in all the phases of its cycle.

used:- 

Carboplatin is used alone or in combination with other medications to treat cancer of the ovaries (cancer that begins in the female reproductive organs where eggs are formed) that has spread to other parts of the body, not improved, or that has worsened after treatment with other medications or radiation therapy.

sides effects:- 

Nausea, Vomiting, Anemia (low number of red blood cells), Low blood platelets, Increased liver enzymes, Decreased white blood cell count (neutrophils), Peripheral neuropathy (tingling and numbness of feet and hand), Diarrhea, Weakness, Hair loss, Taste change, Constipation, Decreased white blood cell count (lymphocytes), Infection, Bleeding, Transfusions, Pain, Sensory disturbance, Central nervous system problems, Visual disturbance, Ototoxicity, Decreased creatinine clearance, Increased creatinine level in blood, Increased blood urea, Increased alkaline phosphatase level in blood, Increased aspartate aminotransferase, Electrolyte imbalance, Hypersensitivity, Skin disorder, Urogenital disorders.

Dose:- 

As directed by your doctor.

Comments

Popular posts from this blog

BOTULINUM TOXIN Uses, Side Effects, and More

 BOTULINUM TOXIN ( A or B ) BRAND NAME:- BOTOX ,DYSPORT  BOTULINUM TOXIN  A and B are highly potent exotoxins produced by Clostridium botulinum that are responsible for ' botulism' ( a type of food poisoning). These neurotoxic proteins cause long- lasting loss of cholinergic transmission by interacting with axonal proteins involved in exocytotic release of Ach. Localized injection of minute quantity of botulinum toxin.  PHARMACODYNAMIC :- Botulinum toxin A inhibits the release of acetylcholine, relieving muscle contraction and spasm associated with many conditions, such as incontinence and dystonia. Cosmetically, botulinum toxin A paralyses muscles in the face to temporarily treat wrinkles. The maximum effects of muscle paralysis occur four to seven days after a dose.When injected at therapeutic doses, botulinum toxin A causes partial chemical denervation of muscle tissue, causing local reduction of muscle activity. Muscle atrophy may result, axonal sprouting may beg...

Clonazepam used, Side effects, Dose, & more

Clonazepam  Brand name:- Lonazepam , Clonapax , Rivotril 0.5, 1.0, 2.0 mg tab. Clonazepam is a benzodiazepine. It works by increasing the action of a chemical messenger (GABA) which suppresses the abnormal and excessive activity of the nerve cells in the brain. Pharmacodynamic:- The pharmacodynamic properties of clonazepam are common among benzodiazepines and include anticonvulsive, sedative, muscle relaxing and anxiolytic effects . Animal data and electroencephalographic investigations in man have shown that clonazepam rapidly suppresses many types of paroxysmal activity including the spike and wave discharge in absence seizures (petit mal), slow spike wave, generalized spike wave, spikes with temporal or other locations, as well as irregular spikes and waves Label . Moreover, the agent can also decrease the frequency, amplitude, duration, and spread of discharge in minor motor seizures Label . Generalized EEG abnormalities are more readily suppressed by clonazepam than are focal ...

CLOMIPHENE CITRATE Uses, Side Effects, and More

 CLOMIPHENE CITRATE BRAND NAME:- CLOMIPHENE, FERTOMED, CLOFERT, CLOME 25,50,100mg tab.  Clomiphene is a selective estrogen receptor modulator (SERM) which treats female infertility. It works by promoting the release of reproductive hormones. This helps stimulate the release of eggs from the ovary (ovulation). PHARMACODYANIMCS:- Clomifene (previously clomiphene) is an orally administered, non steroidal, ovulatory stimulant that acts as a selective estrogen receptor modulator (SERM). Clomifene can lead to multiple ovulation, and hence increase the risk of conceiving twins. In comparison to purified FSH, the rate of ovarian hyperstimulation syndrome is low. There may be an increased risk of ovarian cancer and weight gain. Clomifene is capable of interacting with estrogen-receptor-containing tissues, including the hypothalamus, pituitary, ovary, endometrium, vagina, and cervix. It may compete with estrogen for estrogen-receptor-binding sites and may delay replenishment of intracel...